Protein A Resin Market Size to Surpass Around US$ 3.2 Billion by 2027 | nova one advisor
The global Protein A Resin market gathered revenue around USD 1.9 Billion in 2020 and market is set to grow USD 3.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 10.9% during the prediction period 2021 to 2027. The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, increasing demand for therapeutic antibodies, and the increasing pharmaceutical R&D spending are expected to drive the growth of this market during the forecast period. However, the high cost of resins is expected to limit the growth of this market.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Protein A Resin market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Protein A Resin market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Chromatography is an essential step in the purification of monoclonal antibodies (mAbs). Over the past decade, there has been a tremendous increase in the demand for monoclonal antibodies in oncology and several other therapeutic areas, including neurological, autoimmune, and inflammatory disorders. As a result, almost all major pharmaceutical companies are focusing on the R&D of therapeutic antibodies.
In the purification of monoclonal antibodies, anionic impurities, such as nucleic acids and endotoxins, are removed through chromatography. In drug discovery applications, this process consumes a large amount of resins, as the usage is not limited to purification but also includes the study of the ionic interaction of molecules. Impurities such as albumin and transferrin are removed by size-exclusion chromatography (SEC). High levels of purification can be achieved through the use of protein A affinity resins. This is because antibodies selectively bind protein A ligands with the resins. This is expected to drive the demand for protein A resins during the forecast period.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Protein A Resin market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America is expected to dominate the protein A resin market during the forecast period
Geographically, North America is expected to dominate the global the protein A resin market in 2019, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the increased R&D activities, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub. Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centers in the region. Also, local major players such as Ranbaxy, Dr. Reddy’s, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Protein A Resin Market are:
GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US), Bio-Rad Laboratories (US), Orochem (US), Kaneka Corporation (Japan), Abcam (UK), Agarose Bead Technologies (US), Avantor (US), JSR Life Sciences (US), Bio-Works Technologies (Sweden), Amikozen Co. Ltd. (US), and Takara Bio Inc. (Japan).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Product
By Type
By Application
By End-User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Protein A Resin Market, By Product
7.1. Protein A Resin Market, By Product, 2021-2027
7.1.1. Agarose-based Protein A
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Agarose-based Protein A
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Organic Polymer-based Protein A
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Protein A Resin Market, By Type
8.1. Protein A Resin Market, By Type, 2021-2027
8.1.1. Recombinant Protein A
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Natural Protein A
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Protein A Resin Market, By Application
9.1. Protein A Resin Market, By Application, 2021-2027
9.1.1. Antibody Purification
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Immunoprecipitation
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Protein A Resin Market, By End-User
10.1. Protein A Resin Market, By End-User, 2021-2027
10.1.1. Pharmaceutical & Biopharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Academic Research Institutes
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Other End Users
10.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Protein A Resin Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.2. Market Revenue and Forecast, By Type (2016-2027)
11.1.3. Market Revenue and Forecast, By Application (2016-2027)
11.1.4. Market Revenue and Forecast, By End-User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Type (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.1.5.4. Market Revenue and Forecast, By End-User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Type (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.1.6.4. Market Revenue and Forecast, By End-User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.2. Market Revenue and Forecast, By Type (2016-2027)
11.2.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.4. Market Revenue and Forecast, By End-User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Type (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.5.4. Market Revenue and Forecast, By End-User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Product(2016-2027)
11.2.6.2. Market Revenue and Forecast, By Type (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.6.4. Market Revenue and Forecast, By End-User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Type (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.7.4. Market Revenue and Forecast, By End-User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Type (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Application (2016-2027)
11.2.8.4. Market Revenue and Forecast, By End-User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.2. Market Revenue and Forecast, By Type (2016-2027)
11.3.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.4. Market Revenue and Forecast, By End-User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Type (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.5.4. Market Revenue and Forecast, By End-User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Type (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.6.4. Market Revenue and Forecast, By End-User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Type (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.7.4. Market Revenue and Forecast, By End-User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Type (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Application (2016-2027)
11.3.8.4. Market Revenue and Forecast, By End-User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.2. Market Revenue and Forecast, By Type (2016-2027)
11.4.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.4. Market Revenue and Forecast, By End-User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Type (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.5.4. Market Revenue and Forecast, By End-User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Type (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.6.4. Market Revenue and Forecast, By End-User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Type (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.7.4. Market Revenue and Forecast, By End-User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Type (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Application (2016-2027)
11.4.8.4. Market Revenue and Forecast, By End-User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.2. Market Revenue and Forecast, By Type (2016-2027)
11.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.5.4. Market Revenue and Forecast, By End-User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Type (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Application (2016-2027)
11.5.5.4. Market Revenue and Forecast, By End-User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Type (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Application (2016-2027)
11.5.6.4. Market Revenue and Forecast, By End-User (2016-2027)
Chapter 12. Company Profiles
12.1. GE Healthcare (US)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Merck Millipore (Germany)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Repligen Corporation (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Thermo Fisher Scientific (US)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Tosoh Bioscience (Japan)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Purolite Corporation (US)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Novasep Holding SAS (France)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Agilent Technologies (US)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. GenScript Biotech Corporation (China)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. PerkinElmer (US)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Bio-Rad Laboratories (US)
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Orochem (US)
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Kaneka Corporation (Japan)
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Abcam (UK)
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Agarose Bead Technologies (US)
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
12.16. Avantor (US)
12.16.1. Company Overview
12.16.2. Product Offerings
12.16.3. Financial Performance
12.16.4. Recent Initiatives
12.17. JSR Life Sciences (US)
12.17.1. Company Overview
12.17.2. Product Offerings
12.17.3. Financial Performance
12.17.4. Recent Initiatives
12.18. Bio-Works Technologies (Sweden)
12.18.1. Company Overview
12.18.2. Product Offerings
12.18.3. Financial Performance
12.18.4. Recent Initiatives
12.19. Amikozen Co. Ltd. (US)
12.19.1. Company Overview
12.19.2. Product Offerings
12.19.3. Financial Performance
12.19.4. Recent Initiatives
12.20. Takara Bio Inc. (Japan)
12.20.1. Company Overview
12.20.2. Product Offerings
12.20.3. Financial Performance
12.20.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers